Multiple myeloma in Korea: risk stratification and initial treatment

被引：1
|
作者：
Yoon, Sung-Soo [1 ]
机构：
[1] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea
来源：
BLOOD RESEARCH | 2018年 / 53卷 / 03期
关键词：
D O I：
10.5045/br.2018.53.3.183
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [41] Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in Europe
    Gaultney, Jennifer G.
    Ng, Therese W.
    Uyl-de Groot, Carin A.
    Sonneveld, Pieter
    van Beers, Erik H.
    van Vliet, Martin H.
    Redekop, William K.
    PHARMACOGENOMICS, 2018, 19 (03) : 213 - 226
  • [42] POTENTIAL THERAPEUTIC AND ECONOMIC VALUE OF RISK-STRATIFIED TREATMENT AS INITIAL TREATMENT OF MULTIPLE MYELOMA IN EUROPE
    Gaultney, J. G.
    Ng, T.
    Uyl-de Groot, C. A.
    Sonneveld, P.
    van Beers, E. H.
    van Vliet, M.
    Redekop, W. K.
    VALUE IN HEALTH, 2017, 20 (09) : A444 - A445
  • [43] Treatment of newly diagnosed multiple myeloma based on Mayo stratification of myeloma and risk-adapted therapy (mSMART): Consensus statement
    Dispenzieri, Angela
    Rajkumar, S. Vincent
    Gertz, Morie A.
    Fonseca, Rafael
    Lacy, Martha Q.
    Bergsagel, P. Leif
    Kyle, Robert A.
    Greipp, Philip R.
    Witzig, Thomas E.
    Reeder, Craig B.
    Lust, John A.
    Russell, Stephen J.
    Hayman, Suzmnwe R.
    Roy, Vivek
    Kumar, Shaji
    Zeldenrust, Steven R.
    Dalton, Robert J.
    Stewart, A. Keith
    MAYO CLINIC PROCEEDINGS, 2007, 82 (03) : 323 - 341
  • [44] Antineoplastic agent approved for the initial treatment of multiple myeloma
    不详
    FORMULARY, 2008, 43 (08) : 268 - 268
  • [45] IMPROVE RISK-STRATIFICATION OF MULTIPLE MYELOMA PATIENT WITH MICROFLUIDIC DEVICES
    Li, C.
    Gao, L.
    Zeng, Y.
    Zhang, X.
    Zhong, J.
    HAEMATOLOGICA, 2017, 102 : 774 - 774
  • [46] Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management
    Rajkumar, S. Vincent
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (01) : 79 - 88
  • [47] Myc rearrangement redefines the stratification of high-risk multiple myeloma
    Jin, Xianghong
    Li, Hui
    Zhang, Dingding
    Liu, Shuangjiao
    Song, Yuhang
    Zhang, Fujing
    Li, Ziping
    Zhuang, Junling
    CANCER MEDICINE, 2024, 13 (11):
  • [48] Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
    Kyle, R. A.
    Rajkumar, S. V.
    LEUKEMIA, 2009, 23 (01) : 3 - 9
  • [49] Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma
    Hajek, Roman
    Delforge, Michel
    Raab, Marc S.
    Schoen, Paul
    DeCosta, Lucy
    Spicka, Ivan
    Radocha, Jakub
    Pour, Ludek
    Gonzalez-McQuire, Sebastian
    Bouwmeester, Walter
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (04) : 447 - 458
  • [50] Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
    R A Kyle
    S V Rajkumar
    Leukemia, 2009, 23 : 3 - 9
12345